Sign In
Buy INVA
$21.70
+0.350 (+1.64%)
At Close: Jun 03, 2026
Provention Bio: Undervalued And Overlooked Biotech Company - Diabetes Is Not Going Away Anytime Soon (NASDAQ:PRVB)
02:10pm, Tuesday, 04'th Aug 2020
Teplizumab's At-Risk PHASE II trial showed promising results in significantly delaying the onset of T1D in pre-symptomatic patients by a median of three years relative to placebo.
Q4 2020 EPS Estimates for GlaxoSmithKline plc (NYSE:GSK) Increased by SVB Leerink
02:58am, Tuesday, 04'th Aug 2020
GlaxoSmithKline plc (NYSE:GSK) – Investment analysts at SVB Leerink raised their Q4 2020 earnings per share estimates for GlaxoSmithKline in a report released on Thursday, July 30th. SVB Leerink ana
Coronavirus update: U.S. death toll climbs to 155,000, as COVID-19 enters ‘dangerous new phase’
07:31pm, Monday, 03'rd Aug 2020
The U.S. tally for new confirmed cases of the coronavirus that causes COVID-19 continued its march toward 5 million, with the death toll closing in on...
Sanofi, GSK Nearing EU Supply Deal For 300M Covid-19 Vaccine Doses
12:23pm, Monday, 03'rd Aug 2020
Sanofi (SNYNF) and and GlaxoSmithKline (GSK) are in advanced discussions with the European Commission (EC) for the supply of up to 300 million doses of a
Sanofi pourrait fournir 300 millions de doses de vaccin à l’Union européenne
07:00am, Monday, 03'rd Aug 2020
Sanofi et son partenaire GSK (GlaxoSmithKline) discutent avec Bruxelles pour fournir 300 millions de doses de vaccin contre le Covid-19.,
Avancée sur le front de la lutte contre le coronavirus. Sano
SANOFI et GSK : discussion avancée avec Bruxelles pour fournir 300 millions de doses de vaccin Covid | Zone bourse
06:47am, Monday, 03'rd Aug 2020SANOFI et GSK : discussion avancée avec Bruxelles pour fournir 300 millions de doses de vaccin Covid
06:43am, Monday, 03'rd Aug 2020
(AOF) - Sanofi et GSK sont en discussion avancée avec la Commission européenne (CE) pour la fourniture de jusqu'à 300 millions de doses d'un vaccin Covid-19. Le candidat-vaccin, développé par San
Glaxo, Sanofi to supply EU with vaccine doses
06:20am, Monday, 03'rd Aug 2020
GlaxoSmithKline PLC and Sanofi said on Monday that it is in advanced discussions with the European Union to supply up to 300 million doses of a Covid-19...
Advisor Group Holdings Inc. Acquires Shares of 4,948 Innoviva Inc (NASDAQ:INVA)
05:30am, Monday, 03'rd Aug 2020
Advisor Group Holdings Inc. acquired a new stake in Innoviva Inc (NASDAQ:INVA) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The
Sanofi : en discussions pour le vaccin Covid-19 dans l'UE
05:24am, Monday, 03'rd Aug 2020
(CercleFinance.com) - Sanofi et GSK annoncent avoir conclu des discussions avec la Commission européenne pour la fourniture de jusqu'à 300 millions de doses d'un vaccin Covid-19, dans un cadre contr
How the world’s biggest advertisers are spending (or not) as the pandemic grinds on - Digiday
04:01am, Monday, 03'rd Aug 2020
Having pulled back in Q1, some advertisers are gearing up for a big push in the second half of the year. Others are bracing themselves for a rocky road ahead.
Next big COVID-19 treatment may be manufactured antibodies
12:00am, Monday, 03'rd Aug 2020
Next big COVID-19 treatment may be manufactured antibodies
Sanofi, GSK Ink $2.1B Covid-19 Vaccine Deal From US Government
03:39pm, Sunday, 02'nd Aug 2020
French drugmaker Sanofi (SNYNF) and GlaxoSmithKline (GSK) will be granted up to $2.1 billion by the U.S. government for the development of their
Trump's vaccine chief picks his own former employer for $2.1 billion deal
11:42am, Sunday, 02'nd Aug 2020
The White House on Friday awarded a record-breaking $2.1 billion contract for development of a Covid-19 vaccine, raising questions about a former pharmaceutical executive's involvement in the administ
